vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与PubMatic, Inc.（PUBM）财务数据对比。点击上方公司名可切换其他公司
PubMatic, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.1倍（$80.0M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -6.4%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $11.3M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 9.5%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
PubMatic是一家面向数字出版与广告行业的科技企业，核心开发供应端实时程序化广告交易系统，依托自动化技术连接网站、视频、移动端应用的出版商与广告买家，同时支持用户选择不共享个人信息，目前在全球多国设有办公网点。
PBYI vs PUBM — 直观对比
营收规模更大
PUBM
是对方的1.1倍
$75.5M
营收增速更快
PBYI
高出34.1%
-6.4%
自由现金流更多
PBYI
多$3.1M
$11.3M
两年增速更快
PBYI
近两年复合增速
9.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $80.0M |
| 净利润 | — | — |
| 毛利率 | 69.3% | 68.2% |
| 营业利润率 | 22.7% | 10.6% |
| 净利率 | — | — |
| 营收同比 | 27.7% | -6.4% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.26 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIPUBM
| Q4 25 | $75.5M | $80.0M | ||
| Q3 25 | $54.5M | $68.0M | ||
| Q2 25 | $52.4M | $71.1M | ||
| Q1 25 | $46.0M | $63.8M | ||
| Q4 24 | $59.1M | $85.5M | ||
| Q3 24 | $80.5M | $71.8M | ||
| Q2 24 | $47.1M | $67.3M | ||
| Q1 24 | $43.8M | $66.7M |
净利润PBYIPUBM
| Q4 25 | — | — | ||
| Q3 25 | $8.8M | $-6.5M | ||
| Q2 25 | $5.9M | $-5.2M | ||
| Q1 25 | $3.0M | $-9.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | $20.3M | $-912.0K | ||
| Q2 24 | $-4.5M | $2.0M | ||
| Q1 24 | $-4.8M | $-2.5M |
毛利率PBYIPUBM
| Q4 25 | 69.3% | 68.2% | ||
| Q3 25 | 77.7% | 62.6% | ||
| Q2 25 | 76.5% | 62.6% | ||
| Q1 25 | 77.1% | 59.9% | ||
| Q4 24 | 76.4% | 70.8% | ||
| Q3 24 | 63.9% | 64.5% | ||
| Q2 24 | 77.4% | 62.6% | ||
| Q1 24 | 75.5% | 61.9% |
营业利润率PBYIPUBM
| Q4 25 | 22.7% | 10.6% | ||
| Q3 25 | 17.6% | -12.4% | ||
| Q2 25 | 12.7% | -7.7% | ||
| Q1 25 | 8.7% | -18.6% | ||
| Q4 24 | 22.6% | 17.3% | ||
| Q3 24 | 27.4% | -1.9% | ||
| Q2 24 | -4.6% | -5.9% | ||
| Q1 24 | -5.3% | -8.3% |
净利率PBYIPUBM
| Q4 25 | — | — | ||
| Q3 25 | 16.2% | -9.5% | ||
| Q2 25 | 11.2% | -7.3% | ||
| Q1 25 | 6.5% | -14.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | -1.3% | ||
| Q2 24 | -9.6% | 2.9% | ||
| Q1 24 | -11.0% | -3.7% |
每股收益（稀释后）PBYIPUBM
| Q4 25 | $0.26 | $0.14 | ||
| Q3 25 | $0.17 | $-0.14 | ||
| Q2 25 | $0.12 | $-0.11 | ||
| Q1 25 | $0.06 | $-0.20 | ||
| Q4 24 | $0.40 | $0.26 | ||
| Q3 24 | $0.41 | $-0.02 | ||
| Q2 24 | $-0.09 | $0.04 | ||
| Q1 24 | $-0.10 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $145.5M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $262.6M |
| 总资产 | $216.3M | $680.2M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYIPUBM
| Q4 25 | $97.5M | $145.5M | ||
| Q3 25 | $94.4M | $136.5M | ||
| Q2 25 | $96.0M | $90.5M | ||
| Q1 25 | $93.2M | $101.8M | ||
| Q4 24 | $101.0M | $100.5M | ||
| Q3 24 | $96.7M | $78.9M | ||
| Q2 24 | $96.8M | $73.5M | ||
| Q1 24 | $107.2M | $80.2M |
总债务PBYIPUBM
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIPUBM
| Q4 25 | $130.3M | $262.6M | ||
| Q3 25 | $115.3M | $245.1M | ||
| Q2 25 | $104.7M | $243.3M | ||
| Q1 25 | $97.1M | $275.6M | ||
| Q4 24 | $92.1M | $277.3M | ||
| Q3 24 | $71.1M | $263.2M | ||
| Q2 24 | $48.5M | $282.7M | ||
| Q1 24 | $51.0M | $288.7M |
总资产PBYIPUBM
| Q4 25 | $216.3M | $680.2M | ||
| Q3 25 | $202.9M | $676.2M | ||
| Q2 25 | $194.9M | $675.2M | ||
| Q1 25 | $196.2M | $668.6M | ||
| Q4 24 | $213.3M | $739.5M | ||
| Q3 24 | $220.7M | $689.1M | ||
| Q2 24 | $205.0M | $673.1M | ||
| Q1 24 | $214.1M | $626.2M |
负债/权益比PBYIPUBM
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $18.2M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $11.3M |
| 自由现金流率自由现金流/营收 | 19.1% | 14.1% |
| 资本支出强度资本支出/营收 | 0.0% | 8.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $66.7M |
8季度趋势，按日历期对齐
经营现金流PBYIPUBM
| Q4 25 | $14.4M | $18.2M | ||
| Q3 25 | $9.7M | $32.4M | ||
| Q2 25 | $14.1M | $14.9M | ||
| Q1 25 | $3.6M | $15.6M | ||
| Q4 24 | $15.6M | $18.0M | ||
| Q3 24 | $11.0M | $19.1M | ||
| Q2 24 | $1.0M | $11.9M | ||
| Q1 24 | $11.2M | $24.3M |
自由现金流PBYIPUBM
| Q4 25 | $14.4M | $11.3M | ||
| Q3 25 | $9.7M | $27.7M | ||
| Q2 25 | $14.1M | $13.6M | ||
| Q1 25 | $3.6M | $14.2M | ||
| Q4 24 | $15.6M | $13.7M | ||
| Q3 24 | $11.0M | $7.4M | ||
| Q2 24 | $1.0M | $11.2M | ||
| Q1 24 | — | $23.5M |
自由现金流率PBYIPUBM
| Q4 25 | 19.1% | 14.1% | ||
| Q3 25 | 17.7% | 40.8% | ||
| Q2 25 | 26.8% | 19.1% | ||
| Q1 25 | 7.7% | 22.2% | ||
| Q4 24 | 26.4% | 16.1% | ||
| Q3 24 | 13.7% | 10.3% | ||
| Q2 24 | 2.1% | 16.7% | ||
| Q1 24 | — | 35.2% |
资本支出强度PBYIPUBM
| Q4 25 | 0.0% | 8.6% | ||
| Q3 25 | 0.0% | 6.9% | ||
| Q2 25 | 0.0% | 1.9% | ||
| Q1 25 | 0.1% | 2.3% | ||
| Q4 24 | 0.0% | 5.1% | ||
| Q3 24 | 0.0% | 16.3% | ||
| Q2 24 | 0.0% | 1.1% | ||
| Q1 24 | 0.0% | 1.2% |
现金转化率PBYIPUBM
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | 6.06× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
